TUBA1C
MOLECULAR TARGETtubulin alpha 1c
TUBA1C (tubulin alpha 1c) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TUBA1C
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Colchicine | 4.86 | 128 |
| 2 | Nocodazole Nocodazole is | 3.43 | 30 |
| 3 | Podophyllotoxin | 2.94 | 18 |
| 4 | Vincristine | 2.48 | 11 |
| 5 | Demecolcine | 0.69 | 1 |
| 6 | Maytansine | 0.69 | 1 |
| 7 | Noscapine | 0.69 | 1 |
| 8 | vinblastine sulfate | 0.69 | 1 |
| 9 | Vorinostat | 0.69 | 1 |
About TUBA1C as a Drug Target
TUBA1C (tubulin alpha 1c) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented TUBA1C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TUBA1C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.